We found PTPN1 as a novel modifier of BMPR2 signaling and showed that PTPN1 is decreased in the blood of PAH patients and PTPN1 deficiency is associated with induction of markers of endothelial dysfunction. Here, PTPN1 is linked to endothelial dysfunction.